Building and re-building the heart by cardiomyocyte proliferation

Matthew J Foglia1, Kenneth D Poss2

  • 1Department of Cell Biology, Duke University School of Medicine, Durham, NC 27710, USA.

Development (Cambridge, England)
|March 3, 2016
PubMed

Insights

Adult human hearts struggle to regenerate after injury due to limited cardiomyocyte proliferation. Research aims to understand and enhance this capacity for better cardiac repair and function.

Area of Science:

  • Cardiovascular Research
  • Developmental Biology
  • Regenerative Medicine

Background:

  • Adult mammalian hearts exhibit limited regeneration post-injury, leading to scarring and heart failure.
  • Ineffective cardiac regeneration is primarily attributed to the low proliferative capacity of adult cardiomyocytes.
  • Cardiomyocytes proliferate robustly during development, and some species/neonates show regenerative potential, indicating latent capabilities.

Purpose of the Study:

  • To review current understanding of cardiomyocyte proliferation regulation during heart development.
  • To explore mechanisms underlying the dissipation of proliferative capacity in adult mammals.
  • To identify strategies for boosting cardiomyocyte proliferation for cardiac regeneration.

Main Methods:

  • Review of existing scientific literature on cardiac development and regeneration.
  • Analysis of cellular and molecular mechanisms controlling cardiomyocyte proliferation.
  • Synthesis of findings on factors influencing regenerative potential in different models.

Main Results:

  • Cardiomyocyte proliferation is tightly regulated during development but diminishes significantly in adult mammals.
  • Latent regenerative potential exists, evidenced by neonatal mouse and adult zebrafish cardiac repair.
  • Understanding these regulatory pathways is key to unlocking regenerative capacity.

Conclusions:

  • Mammalian cardiomyocyte proliferation is developmentally programmed and largely lost in adulthood.
  • Targeting the mechanisms that suppress proliferation may enable therapeutic cardiac regeneration.
  • Further research into cardiomyocyte cell cycle control is crucial for treating heart disease.